Equity-Insider.com — The gold sector is undergoing a pivotal shift. Institutional capital is completely rethinking how it values recoverable ounces. According to the World Gold Council , a weakening ...

A 2026 informational overview of how Purisaki Deep Cleansing Foot Pads are described in company materials - including the ...

Relmada Therapeutics, Inc. (NASDAQ:RLMD) Q4 2025 Earnings Call Transcript March 19, 2026 Relmada Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.27 EPS, expectations were ...

Verastem (VSTM) stock receives a "Buy" rating, driven by progress in KRAS G12D-targeted therapies and multiple 2026 catalysts ...

Positive 12-month Phase 2 data for NDV-01 in non-muscle invasive bladder cancer (NMIBC) demonstrated a 95% complete response (CR) rate at any ...

Shenouda With me on today's call are Relmada Therapeutics, Inc.'s CEO, Dr. Sergio Traversa, who will briefly provide a ...

BioCardia, Inc. [Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today reported financial results for the year ...

The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Altona Rare Earths PLC - Africa-focused resource ...

In early March, after Iranian drone attacks on Qatari energy infrastructure, the emirate suspended LNG shipments.

Abeona Therapeutics (ABEO) stock gets a "Buy" rating, driven by ZEVASKYN's commercial launch for RDEB and strong early demand ...

NGEx Minerals Ltd. (“NGEx Minerals” “NGEx” or the “Company”) (TSX: NGEX) (OTCQX: NGXXF) is pleased to report its results for the three months and year ...

Lithium Americas Corp. (TSX: LAC) (NYSE: LAC) (“ Lithium Americas ” or the “ Company ”) announced that it has filed its Annual Report on Form 10-K, which includes the Company’s audited consolidated ...